Monica S. Divakaruni, MD
Cardiovascular Disease (Cardiology) · Saint Helena
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
Offices
5 locations · St. Helena Hospital · Adventist Health Physicians Network · Ukiah Adventist Hospital
Looking this up.
Hospitals listed: Adventist Health Clearlake · Adventist Health Howard Memorial · Adventist Health Mendocino Coast · Adventist Health St Helena · Adventist Health Ukiah Valley. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Divakaruni’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A87860 · Current
Licensed to practise in California · since 2004 · expires 2027-12-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health ClearlakeClearlake, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 4 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
- Adventist Health Howard MemorialWillits, CACritical Access Hospital · Voluntary non-profit - Private · No emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsNo measure marked better or worse than the national rate
- Adventist Health Mendocino CoastFort Bragg, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 5 of 5 · 80% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Adventist Health St HelenaSaint Helena, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative respiratory failure rate: 15.08 (9.46 to 20.69) · 531 cases, Jul 2022 – Jun 2024
- Adventist Health Ukiah ValleyUkiah, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 7.9 (5.8 to 10.5) · 253 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Adventist Health Clearlake
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 8.5 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.6 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.7 · 52 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 358 cases | None | Jul 2024 – Jun 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.497 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 79 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -34.6 · 78 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 0.7 · 130 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 127 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (10.8 to 19) · 488 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 35 cases | No different | Jan 2024 – Dec 2024 |
What patients said (179 patients answered, 19% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 5 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 84% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 70% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 73% |
| Patients who gave a rating of "9" or "10" (high) | 65% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 54% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Adventist Health Howard Memorial
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 11.3 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.4 · 115 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.5 · 51 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 398 cases | None | Jul 2024 – Jun 2025 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 47 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.636 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 56 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 18.4 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -15.3 · 123 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 102 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.2 to 16.7) · 231 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 232 cases | No different | Jan 2024 – Dec 2024 |
What patients said (179 patients answered, 23% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 55% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Adventist Health Mendocino Coast
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 9 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 103 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 268 cases | None | Jul 2024 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 78 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -24.2 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.7 · 102 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 101 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.7 (5.2 to 11.1) · 65 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7.3 to 14.6) · 65 cases | No different | Jan 2024 – Dec 2024 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.8 to 17.4) · 526 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 48 cases | No different | Jan 2024 – Dec 2024 |
What patients said (119 patients answered, 22% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 5 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 86% |
| Doctors "always" communicated well | 89% |
| Staff "always" explained | 72% |
| Yes, staff "did" give patients this information | 94% |
| Yes, staff "did" give patients information about help after discharge | 94% |
| Doctors "always" explained things so they could understand | 85% |
| Doctors "always" listened carefully | 87% |
| Doctors "always" treated them with courtesy and respect | 96% |
| Patients who gave a rating of "9" or "10" (high) | 86% |
| Staff "always" explained new medications | 87% |
| Nurses "always" explained things so they could understand | 82% |
| Nurses "always" listened carefully | 84% |
| Nurses "always" treated them with courtesy and respect | 92% |
| "Always" quiet at night | 56% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 57% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Adventist Health St Helena
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative respiratory failure rateComplications and deaths | 15.08 (9.46 to 20.69) · 531 cases | Worse | Jul 2022 – Jun 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.91 (0 to 1.92) · 430 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.22 (0.89 to 1.55) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 152.62 (102.81 to 202.43) · 69 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 201 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 126 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.5 · 38 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 953 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.06 to 0.48) · 2,438 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,875 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (1.24 to 5.59) · 1,095 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.59 (1.12 to 4.05) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.66 (1.18 to 4.13) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.91 (3.32 to 10.5) · 529 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 91 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.51 (0 to 1.32) · 2,008 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 56 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.568 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.362 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 194 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 153 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.2 · 236 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -41 · 178 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -33.9 · 127 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 116 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.8 to 7.9) · 150 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (8.2 to 14.8) · 150 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 59 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.5 to 17.4) · 1,276 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 841 cases | No different | Jan 2024 – Dec 2024 |
What patients said (573 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 34% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Adventist Health Ukiah Valley
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.9 (5.8 to 10.5) · 253 cases | Worse | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.95) · 319 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.51 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.9 · 137 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 74 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 647 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,093 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.51) · 2,081 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.64 (2.23 to 7.05) · 328 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (0.79 to 4.11) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.96 (0 to 15.74) · 117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.32 (2.24 to 10.4) · 103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.17) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 1.2) · 1,614 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.891 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.607 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.396 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 114 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.9 · 171 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.5 · 270 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (8 to 13.6) · 253 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.4 to 17.4) · 1,320 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 361 cases | No different | Jan 2024 – Dec 2024 |
What patients said (341 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$321,484
Medicare paid this office $321,484 for 1,046 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 621 | $102,949 | $77 |
| Repair of left upper heart chamber with implant with review by radiologist | 56 | $35,419 | $632 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 360 | $22,792 | $58 |
| Return visit (30+ min) | 219 | $22,586 | $83 |
| Replacement of aortic valve through the skin and femoral artery | 37 | $21,586 | $583 |
See all 29 services
| Return visit (30+ min) | 621 | $102,949 | $77 |
| Repair of left upper heart chamber with implant with review by radiologist | 56 | $35,419 | $632 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 360 | $22,792 | $58 |
| Return visit (30+ min) | 219 | $22,586 | $83 |
| Replacement of aortic valve through the skin and femoral artery | 37 | $21,586 | $583 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 93 | $16,333 | $168 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 56 | $12,782 | $228 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 21 | $10,059 | $457 |
| New patient visit (45+ min) | 76 | $8,307 | $109 |
| New patient visit (45+ min) | 39 | $4,963 | $127 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 17 | $3,581 | $211 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $3,240 | $61 |
| Ultrasound of heart, follow-up | 132 | $3,185 | $21 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $2,971 | $248 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $2,819 | $148 |
| Telephone medical discussion with physician, 11-20 minutes | 30 | $2,009 | $57 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 183 | $1,956 | $10 |
| Short return visit (20+ min) | 36 | $1,897 | $51 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,671 | $111 |
| Short return visit (20+ min) | 19 | $1,265 | $60 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 25 | $1,202 | $48 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 56 | $1,189 | $21 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,109 | $85 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $938 | $55 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 80 | $925 | $11 |
| Programming of dual lead pacemaker system | 13 | $472 | $28 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 23 | $419 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 43 | $303 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 24 | $160 | $6 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 47 | More than 80% of doctors who do this |
| Leg revascularization (restoring blood flow) | 1-10 | None |
Who their Medicare patients are
1,046 Original Medicare patients in 2024. Average age 76 · Under 65 4% · 85 and older 16% · Women 53% · Also on Medicaid 22% · Health risk score 1.50. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 49% · Atrial fibrillation 41% · Heart failure 31% · Diabetes 29% · Chronic kidney disease 26% · Cancer 19% · Depression 19% · COPD 18% · Stroke 11% · Dementia 5%.
The office billed $1,324,795, Medicare allowed $423,535 and paid $321,484; for 3,401 services of 72 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,046 | 3,401 | 76 | 1.50 | $1,324,795 | $321,484 |
| 2023 | 1,020 | 3,327 | 76 | 1.43 | $1,403,270 | $288,850 |
| 2022 | 969 | 3,191 | 75 | 1.45 | $1,165,185 | $266,095 |
| 2021 | 853 | 3,224 | 75 | 1.44 | $1,112,701 | $265,694 |
| 2020 | 730 | 2,383 | 75 | 1.62 | $739,949 | $175,383 |
| 2019 | 795 | 3,367 | 75 | 1.52 | $880,586 | $252,991 |
| 2018 | 774 | 2,894 | 75 | 1.58 | $891,364 | $209,340 |
| 2017 | 775 | 2,441 | 74 | 1.63 | $635,553 | $163,417 |
| 2016 | 778 | 2,248 | 75 | 1.66 | $603,428 | $198,367 |
| 2015 | 689 | 1,982 | 75 | 1.62 | $575,382 | $191,956 |
| 2014 | 550 | 1,725 | 73 | 1.56 | $563,735 | $183,037 |
| 2013 | 273 | 635 | 72 | 1.49 | $359,592 | $67,231 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 33 services
| Return visit (30+ min) | 568 | $75,129 | $68 |
| Replacement of aortic valve through the skin and femoral artery | 41 | $24,582 | $600 |
| Repair of left upper heart chamber with implant with review by radiologist | 38 | $24,010 | $632 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 349 | $21,089 | $56 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 102 | $14,753 | $141 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 64 | $14,557 | $224 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 29 | $14,118 | $455 |
| Return visit (30+ min) | 130 | $13,468 | $81 |
| New patient visit (45+ min) | 109 | $10,984 | $101 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 85 | $9,485 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $4,240 | $67 |
| New patient visit (45+ min) | 33 | $3,723 | $113 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 17 | $3,526 | $207 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 52 | $3,479 | $67 |
| Ultrasound of heart, follow-up | 122 | $2,943 | $21 |
| Short return visit (20+ min) | 44 | $2,350 | $50 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 192 | $2,086 | $10 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,672 | $98 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 72 | $1,520 | $21 |
| Ultrasound of heart with probe in esophagus, with report | 18 | $1,515 | $84 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 22 | $1,287 | $59 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 106 | $1,247 | $12 |
| New patient visit (30+ min) | 19 | $1,236 | $65 |
| New patient visit (15+ min) | 29 | $1,103 | $38 |
| Short return visit (20+ min) | 18 | $1,028 | $54 |
| Hospital discharge day management, 30 minutes or less | 15 | $977 | $65 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $912 | $76 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $798 | $53 |
| Programming of dual lead pacemaker system | 24 | $720 | $27 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $699 | $58 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 24 | $491 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 51 | $359 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $32 | $3 |
2022: 33 services
| Return visit (30+ min) | 517 | $70,278 | $69 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 400 | $25,992 | $59 |
| Replacement of aortic valve through the skin and femoral artery | 40 | $24,284 | $607 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 84 | $13,551 | $161 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 26 | $12,607 | $467 |
| Return visit (30+ min) | 96 | $11,822 | $94 |
| New patient visit (45+ min) | 100 | $11,084 | $111 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 47 | $10,756 | $229 |
| Repair of left upper heart chamber with implant with review by radiologist | 17 | $10,574 | $622 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 50 | $5,529 | $111 |
| New patient visit (45+ min) | 32 | $4,391 | $137 |
| Short return visit (20+ min) | 91 | $4,212 | $40 |
| Ultrasound of heart with probe in esophagus, with report | 38 | $3,597 | $92 |
| Short return visit (20+ min) | 44 | $2,678 | $57 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 14 | $2,547 | $182 |
| Ultrasound of heart, follow-up | 98 | $2,532 | $21 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $2,523 | $229 |
| Telephone medical discussion with physician, 11-20 minutes | 49 | $2,515 | $49 |
| New patient visit (30+ min) | 23 | $2,130 | $93 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 73 | $1,703 | $22 |
| New patient visit (30+ min) | 28 | $1,699 | $61 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 160 | $1,695 | $10 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,517 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,509 | $60 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 111 | $1,344 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 70 | $1,243 | $18 |
| Programming of dual lead pacemaker system | 28 | $1,211 | $30 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 20 | $1,186 | $59 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 12 | $717 | $60 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 31 | $664 | $17 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 12 | $508 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 35 | $238 | $7 |
| Heart rhythm recording of continous external ekg over 8-15 days | 13 | $182 | $14 |
2021: 32 services
| Return visit (30+ min) | 424 | $65,491 | $70 |
| Replacement of aortic valve through the skin and femoral artery | 47 | $29,084 | $619 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 382 | $26,547 | $60 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 93 | $15,724 | $167 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 29 | $15,329 | $465 |
| Repair of left upper heart chamber with implant with review by radiologist | 20 | $12,425 | $621 |
| Return visit (30+ min) | 88 | $11,395 | $93 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 44 | $10,415 | $237 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 65 | $7,860 | $114 |
| Short return visit (20+ min) | 129 | $7,304 | $48 |
| New patient visit (45+ min) | 49 | $5,345 | $109 |
| Ultrasound of heart with probe in esophagus, with report | 47 | $5,208 | $85 |
| Telephone medical discussion with physician, 11-20 minutes | 66 | $4,332 | $56 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 16 | $3,486 | $218 |
| New patient visit (30+ min) | 45 | $3,058 | $68 |
| Ultrasound of heart, follow-up | 85 | $2,135 | $21 |
| New patient visit (45+ min) | 16 | $2,118 | $132 |
| Short return visit (20+ min) | 36 | $2,115 | $59 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 172 | $1,894 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 97 | $1,776 | $18 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 70 | $1,758 | $23 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,633 | $86 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 107 | $1,318 | $12 |
| New patient visit (30+ min) | 13 | $974 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $927 | $62 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 15 | $910 | $61 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 32 | $871 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 97 | $729 | $7 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 13 | $553 | $33 |
| Programming of dual lead pacemaker system | 15 | $502 | $26 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 17 | $388 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $149 | $11 |
2020: 26 services
| Return visit (30+ min) | 330 | $34,446 | $64 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 247 | $16,751 | $63 |
| Short return visit (20+ min) | 228 | $12,130 | $42 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 64 | $11,399 | $173 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 21 | $11,380 | $455 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 35 | $8,586 | $245 |
| Return visit (30+ min) | 64 | $5,329 | $74 |
| Ultrasound of heart with probe in esophagus, with report | 47 | $4,921 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,773 | $119 |
| New patient visit (45+ min) | 47 | $4,692 | $100 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 18 | $3,505 | $195 |
| Short return visit (20+ min) | 58 | $3,126 | $50 |
| Telephone medical discussion with physician, 11-20 minutes | 57 | $2,565 | $43 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 67 | $1,720 | $24 |
| New patient visit (30+ min) | 29 | $1,674 | $58 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 127 | $1,494 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 76 | $1,456 | $19 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 18 | $1,141 | $63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 87 | $1,120 | $13 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $980 | $89 |
| Ultrasound of heart, follow-up | 37 | $968 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $899 | $64 |
| Programming of dual lead pacemaker system | 15 | $662 | $35 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 24 | $594 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 77 | $570 | $7 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 12 | $237 | $20 |
2019: 29 services
| Return visit (30+ min) | 382 | $49,892 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 341 | $25,316 | $63 |
| Short return visit (20+ min) | 355 | $21,925 | $38 |
| Replacement of aortic valve through the skin and femoral artery | 25 | $17,816 | $713 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 31 | $16,461 | $457 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 77 | $13,353 | $165 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 41 | $10,005 | $244 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 76 | $9,244 | $117 |
| Return visit (30+ min) | 80 | $9,180 | $93 |
| Repair of left upper heart chamber with implant with review by radiologist | 13 | $6,726 | $517 |
| Short return visit (20+ min) | 84 | $6,633 | $60 |
| New patient visit (45+ min) | 70 | $6,233 | $89 |
| Ultrasound of heart with probe in esophagus, with report | 44 | $5,303 | $95 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 21 | $4,216 | $192 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 87 | $2,088 | $23 |
| New patient visit (45+ min) | 15 | $1,923 | $128 |
| New patient visit (30+ min) | 17 | $1,526 | $90 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 74 | $1,444 | $19 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 127 | $1,423 | $11 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 20 | $1,396 | $66 |
| Ultrasound of heart, follow-up | 48 | $1,320 | $22 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,269 | $63 |
| New patient visit (30+ min) | 20 | $1,250 | $63 |
| Long return visit (40+ min) | 13 | $1,249 | $96 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 136 | $1,033 | $7 |
| Programming of dual lead pacemaker system | 26 | $1,014 | $31 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 76 | $1,000 | $13 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 28 | $759 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $333 | $14 |
2018: 29 services
| Return visit (30+ min) | 259 | $28,342 | $63 |
| Short return visit (20+ min) | 365 | $26,872 | $40 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 347 | $24,966 | $64 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 85 | $14,121 | $162 |
| Replacement of aortic valve through the skin and femoral artery | 17 | $12,551 | $697 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 48 | $11,191 | $233 |
| Short return visit (20+ min) | 155 | $11,007 | $51 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 20 | $10,653 | $533 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $9,743 | $443 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 71 | $8,673 | $117 |
| New patient visit (45+ min) | 62 | $5,260 | $85 |
| Balloon dilation of single coronary artery or branch | 11 | $4,501 | $409 |
| Ultrasound of heart with probe in esophagus, with report | 33 | $3,331 | $95 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 15 | $2,737 | $182 |
| New patient visit (30+ min) | 32 | $2,696 | $84 |
| Return visit (30+ min) | 32 | $2,606 | $77 |
| New patient visit (45+ min) | 12 | $1,619 | $135 |
| Programming of dual lead pacemaker system | 31 | $1,459 | $32 |
| Ultrasound of heart, follow-up | 55 | $1,412 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 128 | $1,398 | $11 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 49 | $1,316 | $23 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 15 | $1,202 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $991 | $90 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 15 | $889 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 111 | $860 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $818 | $63 |
| Programming of dual lead implantable defibrillator system | 12 | $807 | $47 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 20 | $379 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 29 | $376 | $13 |
2017: 27 services
| Short return visit (20+ min) | 321 | $30,137 | $39 |
| Short return visit (20+ min) | 223 | $24,199 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 313 | $18,428 | $55 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $12,836 | $475 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 88 | $10,815 | $116 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 60 | $9,976 | $164 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 42 | $9,702 | $231 |
| Replacement of aortic valve through the skin and femoral artery | 13 | $9,131 | $702 |
| New patient visit (30+ min) | 41 | $3,527 | $86 |
| New patient visit (30+ min) | 60 | $2,694 | $45 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 12 | $2,633 | $219 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $2,152 | $90 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $1,796 | $95 |
| Return visit (30+ min) | 22 | $1,360 | $62 |
| Programming of dual lead pacemaker system | 23 | $1,239 | $33 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,063 | $59 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 13 | $1,041 | $80 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 61 | $868 | $14 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 13 | $808 | $62 |
| Ultrasound of heart, follow-up | 25 | $672 | $22 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 25 | $594 | $23 |
| External ekg recording for more than 48 hours up to 21 days | 18 | $404 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 15 | $375 | $18 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 14 | $319 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 38 | $307 | $7 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | $296 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $195 | $13 |
2016: 27 services
| Return visit (30+ min) | 289 | $31,613 | $68 |
| Short return visit (20+ min) | 284 | $19,765 | $51 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 75 | $16,763 | $224 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 32 | $15,068 | $443 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 241 | $14,535 | $53 |
| Replacement of aortic valve through the skin and femoral artery | 17 | $11,985 | $705 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 94 | $11,140 | $114 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 45 | $7,725 | $168 |
| New patient visit (45+ min) | 83 | $6,964 | $84 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 23 | $6,915 | $301 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 40 | $6,099 | $145 |
| Short return visit (20+ min) | 101 | $4,863 | $44 |
| Balloon dilation of single coronary artery or branch | 11 | $4,799 | $400 |
| Ultrasound of heart with probe in esophagus, with report | 36 | $3,911 | $103 |
| Return visit (30+ min) | 47 | $3,650 | $64 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 41 | $2,763 | $67 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 16 | $1,289 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,249 | $62 |
| New patient visit (30+ min) | 17 | $1,225 | $72 |
| Programming of dual lead pacemaker system | 19 | $796 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 55 | $664 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 26 | $504 | $19 |
| External ekg recording for more than 48 hours up to 21 days | 21 | $495 | $24 |
| Ultrasound of heart, follow-up | 20 | $451 | $23 |
| Programming of dual lead pacemaker system | 13 | $411 | $32 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 18 | $407 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 28 | $354 | $13 |
2015: 24 services
| Return visit (30+ min) | 294 | $49,714 | $85 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 87 | $20,385 | $232 |
| New patient visit (45+ min) | 123 | $15,925 | $129 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 247 | $13,891 | $53 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 101 | $11,901 | $114 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $10,006 | $500 |
| Return visit (30+ min) | 107 | $8,781 | $58 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 12 | $6,614 | $551 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 34 | $6,080 | $179 |
| Short return visit (20+ min) | 64 | $4,045 | $58 |
| New patient visit (45+ min) | 36 | $3,864 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $3,645 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $2,805 | $187 |
| Insertion of tube in bypass graft for diagnosis with review by radiologist | 11 | $2,592 | $216 |
| Ultrasound of heart with probe in esophagus, with report | 20 | $2,201 | $105 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 20 | $1,620 | $81 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 18 | $1,271 | $71 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 66 | $1,138 | $14 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,018 | $85 |
| External ekg recording for more than 48 hours up to 21 days | 35 | $789 | $22 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 31 | $725 | $22 |
| Short return visit (20+ min) | 15 | $624 | $42 |
| Programming of dual lead pacemaker system | 12 | $552 | $39 |
| Ultrasound of heart, follow-up | 15 | $424 | $22 |
2014: 23 services
| Return visit (30+ min) | 194 | $31,279 | $90 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 88 | $19,892 | $224 |
| Long return visit (40+ min) | 95 | $18,567 | $117 |
| New patient visit (60+ min) | 89 | $14,189 | $159 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 26 | $13,512 | $500 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 99 | $12,285 | $117 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 190 | $11,281 | $55 |
| New patient visit (45+ min) | 61 | $8,050 | $132 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 18 | $5,573 | $310 |
| Return visit (30+ min) | 52 | $4,982 | $68 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 24 | $4,283 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $3,772 | $62 |
| Short return visit (20+ min) | 43 | $2,681 | $60 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 25 | $1,856 | $74 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $1,632 | $91 |
| New patient visit (45+ min) | 14 | $1,479 | $106 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 19 | $1,460 | $77 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 86 | $1,358 | $13 |
| Short return visit (20+ min) | 11 | $529 | $33 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 20 | $402 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 20 | $264 | $13 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 12 | $227 | $19 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 11 | $78 | $7 |
2013: 18 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 24 | $12,809 | $457 |
| New patient visit (45+ min) | 38 | $5,053 | $133 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 28 | $4,374 | $156 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 79 | $4,287 | $53 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $4,157 | $208 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $3,824 | $255 |
| Return visit (30+ min) | 33 | $3,767 | $90 |
| Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,261 | $272 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $3,180 | $86 |
| Short return visit (20+ min) | 43 | $2,710 | $38 |
| New patient visit (60+ min) | 12 | $1,895 | $158 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,475 | $113 |
| Return visit (30+ min) | 17 | $1,396 | $66 |
| Short return visit (20+ min) | 19 | $1,359 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,311 | $60 |
| New patient visit (30+ min) | 21 | $1,057 | $50 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 12 | $894 | $75 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $437 | $15 |
Medicaid work
$7,810 in 2024
Medicaid paid $7,810 for 293 billed services this clinician did in 2024, up to 37 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 280 | $7,151 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 13 | $659 |
| 2024 | 293 | 2 | 37 | $7,810 |
| 2023 | 359 | 3 | 37 | $11,978 |
| 2022 | 228 | 2 | 20 | $8,572 |
| 2021 | 403 | 3 | 28 | $15,560 |
| 2020 | 121 | 3 | 18 | $4,006 |
| 2019 | 57 | 2 | 18 | $1,420 |
| 2018 | 75 | 2 | 19 | $2,441 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 259 | $7,716 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 68 | $3,345 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 32 | $917 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 97 | $5,300 |
| Return visit (30+ min) | 131 | $3,272 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 159 | $9,574 |
| Return visit (30+ min) | 231 | $5,836 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 13 | $151 |
2020
| Return visit (30+ min) | 92 | $2,976 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 15 | $714 |
| Short return visit (20+ min) | 14 | $316 |
2019
| Return visit (30+ min) | 44 | $1,161 |
| Short return visit (20+ min) | 13 | $259 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 45 | $1,899 |
| Short return visit (20+ min) | 30 | $541 |
Drugs they prescribed that Part D paid
$1,257,930
Pharmacies billed $1,257,930 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 6,898) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
5,707 generic and 1,191 brand-name prescriptions · $1,257,930 in drug cost · 30 antibiotic prescriptions to 22 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 400 | $395,051 | $988 |
| Entresto | 201 | $237,759 | $1,183 |
| Repatha Sureclick | 247 | $227,142 | $920 |
| Xarelto | 90 | $112,378 | $1,249 |
| Jardiance | 63 | $69,966 | $1,111 |
See all 52 drugs
| Eliquis | 400 | $395,051 | $988 |
| Entresto | 201 | $237,759 | $1,183 |
| Repatha Sureclick | 247 | $227,142 | $920 |
| Xarelto | 90 | $112,378 | $1,249 |
| Jardiance | 63 | $69,966 | $1,111 |
| Praluent | 56 | $51,532 | $920 |
| Brilinta | 18 | $10,619 | $590 |
| Ezetimibe | 293 | $7,920 | $27 |
| Ranolazine Er | 95 | $6,793 | $72 |
| Rosuvastatin | 455 | $6,244 | $14 |
| Nebivolol | 48 | $5,524 | $115 |
| Metoprolol | 483 | $5,343 | $11 |
| Atorvastatin | 546 | $4,305 | $8 |
| Losartan | 535 | $4,195 | $8 |
| Fenofibrate | 48 | $2,993 | $62 |
| Amlodipine Besylate | 599 | $2,834 | $5 |
| Midodrine | 14 | $2,770 | $198 |
| Isosorbide Mononitrate Er | 266 | $2,704 | $10 |
| Clopidogrel | 231 | $2,486 | $11 |
| Pindolol | 20 | $2,454 | $123 |
| Metoprolol | 320 | $1,939 | $6 |
| Carvedilol | 205 | $1,873 | $9 |
| Lisinopril | 249 | $1,609 | $6 |
| Potassium Chloride | 89 | $1,566 | $18 |
| Nitroglycerin | 43 | $1,537 | $36 |
| Furosemide | 269 | $1,232 | $5 |
| Telmisartan | 25 | $1,182 | $47 |
| Diltiazem 24hr Er (Cd) | 58 | $978 | $17 |
| Verapamil Er | 23 | $948 | $41 |
| Bisoprolol | 19 | $900 | $47 |
| Nifedipine Er | 39 | $880 | $23 |
| Amiodarone | 23 | $795 | $35 |
| Ramipril | 36 | $735 | $20 |
| Hydralazine | 75 | $636 | $8 |
| Spironolactone | 85 | $593 | $7 |
| Olmesartan Medoxomil | 32 | $568 | $18 |
| Torsemide | 16 | $459 | $29 |
| Warfarin | 33 | $407 | $12 |
| Pantoprazole | 29 | $378 | $13 |
| Hydrochlorothiazide | 64 | $340 | $5 |
| Flecainide Acetate | 13 | $313 | $24 |
| Benazepril | 20 | $304 | $15 |
| Losartan-Hydrochlorothiazide | 22 | $281 | $13 |
| Simvastatin | 44 | $211 | $5 |
| Valsartan | 25 | $209 | $8 |
| Diltiazem 24hr Er | 11 | $190 | $17 |
| Atenolol | 26 | $135 | $5 |
| Irbesartan | 11 | $116 | $11 |
| Triamterene-Hydrochlorothiazid | 14 | $109 | $8 |
| Clonidine | 16 | $93 | $6 |
| Pravastatin | 12 | $29 | $2 |
| Amoxicillin | 21 | $16 | $1 |
Year by year
| 2024 | 6,898 | 726 | 0% (0) | 17% | $1,257,930 |
| 2023 | 6,066 | 660 | 0% (0) | 18% | $1,302,027 |
| 2022 | 4,855 | 580 | 0% (0) | 17% | $829,393 |
| 2021 | 3,090 | 489 | None | 13% | $370,746 |
| 2020 | 2,684 | 473 | None | 18% | $364,385 |
| 2019 | 3,524 | 432 | None | 18% | $450,443 |
| 2018 | 2,465 | 368 | 0% (0) | 15% | $242,147 |
| 2017 | 2,284 | 364 | None | None | $173,062 |
| 2016 | 2,335 | 378 | 0% (0) | 18% | $157,421 |
| 2015 | 1,850 | 325 | 0% (0) | 18% | $111,135 |
| 2014 | 1,251 | 217 | None | 17% | $63,437 |
| 2013 | 472 | 111 | None | 19% | $24,728 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 51 drugs
| Eliquis | 361 | $373,741 | $1,035 |
| Entresto | 238 | $261,385 | $1,098 |
| Repatha Sureclick | 178 | $131,039 | $736 |
| Xarelto | 80 | $101,010 | $1,263 |
| Praluent | 70 | $58,744 | $839 |
| Jardiance | 33 | $29,638 | $898 |
| Ezetimibe | 193 | $11,655 | $60 |
| Rosuvastatin | 404 | $9,385 | $23 |
| Repatha | 15 | $8,846 | $590 |
| Ranolazine Er | 56 | $8,633 | $154 |
| Atorvastatin | 460 | $6,734 | $15 |
| Amlodipine Besylate | 577 | $6,091 | $11 |
| Metoprolol | 384 | $6,074 | $16 |
| Losartan | 412 | $5,729 | $14 |
| Nebivolol | 52 | $4,503 | $87 |
| Isosorbide Mononitrate Er | 213 | $4,302 | $20 |
| Clopidogrel | 221 | $3,830 | $17 |
| Metoprolol | 344 | $3,066 | $9 |
| Carvedilol | 211 | $3,044 | $14 |
| Amiodarone | 27 | $2,800 | $104 |
| Potassium Chloride | 100 | $2,612 | $26 |
| Lisinopril | 261 | $2,579 | $10 |
| Pindolol | 18 | $2,058 | $114 |
| Diltiazem 24hr Er (Cd) | 51 | $2,009 | $39 |
| Fenofibrate | 15 | $1,586 | $106 |
| Nifedipine Er | 44 | $1,529 | $35 |
| Torsemide | 27 | $1,401 | $52 |
| Flecainide Acetate | 26 | $1,283 | $49 |
| Nitroglycerin | 53 | $1,166 | $22 |
| Spironolactone | 82 | $1,080 | $13 |
| Furosemide | 197 | $1,060 | $5 |
| Bisoprolol | 20 | $983 | $49 |
| Ramipril | 40 | $860 | $22 |
| Irbesartan | 18 | $780 | $43 |
| Propafenone | 17 | $775 | $46 |
| Simvastatin | 45 | $722 | $16 |
| Verapamil Er | 15 | $700 | $47 |
| Telmisartan | 22 | $624 | $28 |
| Hydralazine | 49 | $620 | $13 |
| Benazepril | 17 | $534 | $31 |
| Olmesartan Medoxomil | 16 | $463 | $29 |
| Losartan-Hydrochlorothiazide | 14 | $426 | $30 |
| Warfarin | 29 | $394 | $14 |
| Hydrochlorothiazide | 55 | $383 | $7 |
| Pantoprazole | 26 | $356 | $14 |
| Fenofibrate | 15 | $303 | $20 |
| Spironolactone-Hctz | 11 | $294 | $27 |
| Digoxin | 16 | $238 | $15 |
| Pravastatin | 11 | $201 | $18 |
| Triamterene-Hydrochlorothiazid | 17 | $165 | $10 |
| Atenolol | 16 | $80 | $5 |
2022: 43 drugs
| Eliquis | 298 | $318,988 | $1,070 |
| Entresto | 180 | $217,498 | $1,208 |
| Repatha Sureclick | 105 | $70,965 | $676 |
| Xarelto | 51 | $54,026 | $1,059 |
| Praluent | 53 | $40,097 | $757 |
| Ezetimibe | 183 | $15,297 | $84 |
| Rosuvastatin | 293 | $11,152 | $38 |
| Metoprolol | 316 | $8,050 | $25 |
| Atorvastatin | 390 | $5,302 | $14 |
| Amlodipine Besylate | 489 | $4,979 | $10 |
| Clopidogrel | 192 | $4,274 | $22 |
| Losartan | 347 | $3,973 | $11 |
| Isosorbide Mononitrate Er | 188 | $3,863 | $21 |
| Nebivolol | 34 | $3,493 | $103 |
| Carvedilol | 186 | $2,727 | $15 |
| Diltiazem 24hr Er (Cd) | 45 | $2,608 | $58 |
| Nifedipine Er | 31 | $2,330 | $75 |
| Potassium Chloride | 100 | $2,324 | $23 |
| Lisinopril | 222 | $2,217 | $10 |
| Metoprolol | 238 | $2,205 | $9 |
| Pindolol | 17 | $1,572 | $92 |
| Flecainide Acetate | 21 | $1,207 | $57 |
| Amiodarone | 36 | $1,150 | $32 |
| Torsemide | 36 | $1,075 | $30 |
| Furosemide | 190 | $1,053 | $6 |
| Nitroglycerin | 45 | $1,014 | $23 |
| Irbesartan | 11 | $901 | $82 |
| Benazepril | 24 | $723 | $30 |
| Ramipril | 32 | $709 | $22 |
| Fenofibrate | 16 | $672 | $42 |
| Verapamil Er | 16 | $660 | $41 |
| Hydralazine | 34 | $592 | $17 |
| Spironolactone | 58 | $531 | $9 |
| Simvastatin | 31 | $441 | $14 |
| Bisoprolol | 12 | $410 | $34 |
| Triamterene-Hydrochlorothiazid | 23 | $392 | $17 |
| Pantoprazole | 12 | $353 | $29 |
| Hydrochlorothiazide | 54 | $343 | $6 |
| Olmesartan Medoxomil | 14 | $320 | $23 |
| Losartan-Hydrochlorothiazide | 14 | $269 | $19 |
| Warfarin | 18 | $196 | $11 |
| Pravastatin | 11 | $175 | $16 |
| Atenolol | 11 | $128 | $12 |
2021: 36 drugs
| Eliquis | 173 | $159,418 | $921 |
| Entresto | 84 | $74,001 | $881 |
| Xarelto | 20 | $25,697 | $1,285 |
| Repatha Sureclick | 29 | $24,971 | $861 |
| Praluent | 24 | $11,447 | $477 |
| Ezetimibe | 102 | $7,995 | $78 |
| Rosuvastatin | 163 | $7,421 | $46 |
| Bystolic | 20 | $4,689 | $234 |
| Metoprolol | 197 | $4,543 | $23 |
| Atorvastatin | 246 | $3,033 | $12 |
| Losartan | 254 | $2,978 | $12 |
| Isosorbide Mononitrate Er | 145 | $2,956 | $20 |
| Prasugrel | 11 | $2,864 | $260 |
| Amlodipine Besylate | 256 | $2,557 | $10 |
| Diltiazem 24hr Er (Cd) | 44 | $2,138 | $49 |
| Clopidogrel | 134 | $1,769 | $13 |
| Potassium Chloride | 51 | $1,591 | $31 |
| Carvedilol | 103 | $1,515 | $15 |
| Lisinopril | 162 | $1,470 | $9 |
| Nitroglycerin | 52 | $1,410 | $27 |
| Metoprolol | 206 | $1,387 | $7 |
| Amiodarone | 27 | $1,031 | $38 |
| Nifedipine Er | 19 | $999 | $53 |
| Torsemide | 31 | $714 | $23 |
| Furosemide | 107 | $544 | $5 |
| Ramipril | 24 | $533 | $22 |
| Hydralazine | 30 | $449 | $15 |
| Simvastatin | 32 | $414 | $13 |
| Benazepril | 18 | $362 | $20 |
| Olmesartan Medoxomil | 11 | $313 | $28 |
| Hydrochlorothiazide | 42 | $269 | $6 |
| Triamterene-Hydrochlorothiazid | 18 | $239 | $13 |
| Pantoprazole | 14 | $230 | $16 |
| Warfarin | 25 | $175 | $7 |
| Clonidine | 15 | $153 | $10 |
| Spironolactone | 16 | $152 | $9 |
2020: 38 drugs
| Eliquis | 201 | $163,027 | $811 |
| Xarelto | 40 | $44,154 | $1,104 |
| Entresto | 48 | $38,330 | $799 |
| Praluent | 34 | $25,969 | $764 |
| Brilinta | 20 | $10,447 | $522 |
| Repatha Sureclick | 20 | $9,719 | $486 |
| Pradaxa | 12 | $7,205 | $600 |
| Rosuvastatin | 133 | $6,162 | $46 |
| Bystolic | 16 | $5,525 | $345 |
| Prasugrel | 42 | $5,063 | $121 |
| Ezetimibe | 68 | $4,960 | $73 |
| Atorvastatin | 220 | $3,198 | $15 |
| Metoprolol | 108 | $2,928 | $27 |
| Losartan | 182 | $2,577 | $14 |
| Midodrine | 11 | $2,085 | $190 |
| Isosorbide Mononitrate Er | 93 | $2,052 | $22 |
| Amlodipine Besylate | 191 | $1,846 | $10 |
| Clopidogrel | 124 | $1,797 | $14 |
| Nifedipine Er | 28 | $1,687 | $60 |
| Potassium Chloride | 49 | $1,501 | $31 |
| Flecainide Acetate | 24 | $1,465 | $61 |
| Metoprolol | 191 | $1,376 | $7 |
| Carvedilol | 128 | $1,305 | $10 |
| Diltiazem 24hr Er (Cd) | 32 | $1,269 | $40 |
| Lisinopril | 110 | $908 | $8 |
| Ramipril | 37 | $840 | $23 |
| Simvastatin | 50 | $541 | $11 |
| Benazepril | 23 | $467 | $20 |
| Furosemide | 72 | $416 | $6 |
| Levothyroxine | 17 | $389 | $23 |
| Nitroglycerin | 17 | $337 | $20 |
| Verapamil Er | 16 | $335 | $21 |
| Hydralazine | 27 | $328 | $12 |
| Pantoprazole | 15 | $302 | $20 |
| Hydrochlorothiazide | 35 | $242 | $7 |
| Triamterene-Hydrochlorothiazid | 13 | $230 | $18 |
| Spironolactone | 13 | $200 | $15 |
| Warfarin | 27 | $176 | $7 |
2019: 44 drugs
| Eliquis | 230 | $198,713 | $864 |
| Brilinta | 59 | $44,701 | $758 |
| Entresto | 54 | $35,595 | $659 |
| Xarelto | 28 | $27,742 | $991 |
| Rosuvastatin | 140 | $10,483 | $75 |
| Bystolic | 32 | $10,398 | $325 |
| Praluent | 12 | $10,293 | $858 |
| Repatha Sureclick | 18 | $9,165 | $509 |
| Repatha | 13 | $9,115 | $701 |
| Atorvastatin | 242 | $4,967 | $21 |
| Metoprolol | 106 | $4,256 | $40 |
| Prasugrel | 29 | $4,098 | $141 |
| Ezetimibe | 108 | $3,804 | $35 |
| Isosorbide Mononitrate Er | 168 | $3,752 | $22 |
| Amlodipine Besylate | 346 | $3,183 | $9 |
| Nifedipine Er | 39 | $2,372 | $61 |
| Carvedilol | 208 | $2,347 | $11 |
| Losartan | 220 | $2,342 | $11 |
| Potassium Chloride | 79 | $2,292 | $29 |
| Metoprolol | 233 | $2,110 | $9 |
| Verapamil | 12 | $1,891 | $158 |
| Clopidogrel | 92 | $1,834 | $20 |
| Eplerenone | 11 | $1,507 | $137 |
| Lisinopril | 137 | $1,465 | $11 |
| Ramipril | 38 | $1,447 | $38 |
| Flecainide Acetate | 32 | $1,445 | $45 |
| Nitroglycerin | 53 | $1,393 | $26 |
| Hydralazine | 60 | $925 | $15 |
| Simvastatin | 90 | $915 | $10 |
| Diltiazem 24hr Er (Cd) | 24 | $625 | $26 |
| Olmesartan Medoxomil | 26 | $587 | $23 |
| Diltiazem 24hr Er (La) | 11 | $555 | $50 |
| Furosemide | 82 | $554 | $7 |
| Spironolactone | 62 | $533 | $9 |
| Amiodarone | 21 | $490 | $23 |
| Omeprazole | 19 | $416 | $22 |
| Verapamil Er | 15 | $389 | $26 |
| Pantoprazole | 27 | $361 | $13 |
| Hydrochlorothiazide | 50 | $350 | $7 |
| Benazepril | 25 | $316 | $13 |
| Warfarin | 23 | $276 | $12 |
| Torsemide | 12 | $219 | $18 |
| Losartan-Hydrochlorothiazide | 12 | $181 | $15 |
| Fenofibrate | 12 | $143 | $12 |
2018: 35 drugs
| Eliquis | 147 | $104,586 | $711 |
| Entresto | 49 | $31,839 | $650 |
| Brilinta | 23 | $17,218 | $749 |
| Xarelto | 16 | $13,532 | $846 |
| Ezetimibe | 88 | $8,125 | $92 |
| Bystolic | 26 | $6,649 | $256 |
| Fenofibrate | 11 | $5,143 | $468 |
| Rosuvastatin | 64 | $3,889 | $61 |
| Atorvastatin | 160 | $2,715 | $17 |
| Amlodipine Besylate | 288 | $2,713 | $9 |
| Isosorbide Mononitrate Er | 133 | $2,705 | $20 |
| Metoprolol | 55 | $2,340 | $43 |
| Nitroglycerin | 32 | $1,416 | $44 |
| Clopidogrel | 85 | $1,238 | $15 |
| Carvedilol | 168 | $1,205 | $7 |
| Metoprolol | 137 | $1,176 | $9 |
| Losartan | 131 | $1,136 | $9 |
| Lisinopril | 117 | $1,053 | $9 |
| Potassium Chloride | 41 | $903 | $22 |
| Ramipril | 31 | $778 | $25 |
| Flecainide Acetate | 14 | $679 | $49 |
| Simvastatin | 61 | $576 | $9 |
| Nifedipine Er | 12 | $558 | $46 |
| Verapamil Er | 14 | $550 | $39 |
| Diltiazem 24hr Er (Cd) | 28 | $524 | $19 |
| Furosemide | 88 | $522 | $6 |
| Hydralazine | 31 | $498 | $16 |
| Warfarin | 37 | $478 | $13 |
| Benazepril | 28 | $408 | $15 |
| Spironolactone | 41 | $368 | $9 |
| Amiodarone | 11 | $231 | $21 |
| Pantoprazole | 16 | $203 | $13 |
| Ranitidine | 12 | $156 | $13 |
| Fenofibrate | 12 | $125 | $10 |
| Hydrochlorothiazide | 18 | $91 | $5 |
2017: 36 drugs
| Eliquis | 108 | $69,510 | $644 |
| Xarelto | 15 | $14,624 | $975 |
| Entresto | 14 | $10,248 | $732 |
| Effient | 11 | $9,812 | $892 |
| Zetia | 13 | $5,678 | $437 |
| Ezetimibe | 32 | $5,282 | $165 |
| Bystolic | 29 | $5,135 | $177 |
| Atorvastatin | 131 | $2,570 | $20 |
| Clopidogrel | 127 | $2,147 | $17 |
| Metoprolol | 65 | $2,147 | $33 |
| Isosorbide Mononitrate Er | 134 | $2,135 | $16 |
| Rosuvastatin | 36 | $2,074 | $58 |
| Amlodipine Besylate | 214 | $1,961 | $9 |
| Ramipril | 54 | $1,267 | $23 |
| Carvedilol | 137 | $1,086 | $8 |
| Nitroglycerin | 27 | $1,077 | $40 |
| Simvastatin | 90 | $1,030 | $11 |
| Losartan | 114 | $1,016 | $9 |
| Lisinopril | 123 | $1,004 | $8 |
| Verapamil Er | 21 | $880 | $42 |
| Diltiazem 24hr Er | 36 | $689 | $19 |
| Digoxin | 17 | $610 | $36 |
| Hydralazine | 17 | $581 | $34 |
| Metoprolol | 96 | $565 | $6 |
| Potassium Chloride | 23 | $558 | $24 |
| Valsartan | 15 | $556 | $37 |
| Furosemide | 109 | $522 | $5 |
| Warfarin | 35 | $486 | $14 |
| Spironolactone | 40 | $480 | $12 |
| Amiodarone | 34 | $439 | $13 |
| Lactated Ringers | 52 | $436 | $8 |
| Telmisartan | 11 | $401 | $36 |
| Benazepril | 26 | $282 | $11 |
| Nifedipine Er | 13 | $271 | $21 |
| Clonidine | 11 | $105 | $10 |
| Hydrochlorothiazide | 16 | $77 | $5 |
2016: 32 drugs
| Eliquis | 67 | $45,245 | $675 |
| Crestor | 35 | $18,253 | $522 |
| Xarelto | 23 | $16,775 | $729 |
| Bystolic | 35 | $7,440 | $213 |
| Zetia | 17 | $6,372 | $375 |
| Atorvastatin | 158 | $3,742 | $24 |
| Metoprolol | 88 | $3,545 | $40 |
| Clopidogrel | 213 | $3,195 | $15 |
| Isosorbide Mononitrate Er | 126 | $2,378 | $19 |
| Carvedilol | 137 | $1,504 | $11 |
| Amlodipine Besylate | 182 | $1,464 | $8 |
| Nitrostat | 25 | $1,381 | $55 |
| Lisinopril | 196 | $1,379 | $7 |
| Losartan | 90 | $1,335 | $15 |
| Verapamil Er | 37 | $1,325 | $36 |
| Ramipril | 42 | $1,264 | $30 |
| Diltiazem 24hr Er | 11 | $872 | $79 |
| Spironolactone | 53 | $797 | $15 |
| Simvastatin | 92 | $794 | $9 |
| Diltiazem 24hr Cd | 27 | $736 | $27 |
| Metoprolol | 107 | $694 | $6 |
| Amiodarone | 23 | $620 | $27 |
| Valsartan | 21 | $608 | $29 |
| Warfarin | 51 | $596 | $12 |
| Verapamil Er Pm | 13 | $539 | $41 |
| Nitroglycerin | 13 | $493 | $38 |
| Furosemide | 93 | $491 | $5 |
| Flecainide Acetate | 13 | $343 | $26 |
| Potassium Chloride | 27 | $333 | $12 |
| Lactated Ringers | 32 | $246 | $8 |
| Hydrochlorothiazide | 29 | $244 | $8 |
| Torsemide | 11 | $104 | $9 |
2015: 31 drugs
| Xarelto | 30 | $22,919 | $764 |
| Crestor | 48 | $19,566 | $408 |
| Eliquis | 24 | $17,086 | $712 |
| Bystolic | 40 | $6,228 | $156 |
| Combivent Respimat | 11 | $3,174 | $289 |
| Isosorbide Mononitrate Er | 159 | $2,971 | $19 |
| Metoprolol | 39 | $2,856 | $73 |
| Clopidogrel | 138 | $2,533 | $18 |
| Atorvastatin | 70 | $1,756 | $25 |
| Amlodipine Besylate | 182 | $1,410 | $8 |
| Carvedilol | 163 | $1,138 | $7 |
| Diltiazem 24hr Cd | 21 | $1,032 | $49 |
| Lisinopril | 127 | $881 | $7 |
| Losartan | 91 | $873 | $10 |
| Warfarin | 51 | $835 | $16 |
| Metoprolol | 108 | $785 | $7 |
| Valsartan | 11 | $761 | $69 |
| Nitrostat | 22 | $615 | $28 |
| Simvastatin | 80 | $543 | $7 |
| Furosemide | 72 | $470 | $7 |
| Verapamil Er | 17 | $449 | $26 |
| Ramipril | 20 | $399 | $20 |
| Amiodarone | 21 | $398 | $19 |
| Potassium Chloride | 19 | $350 | $18 |
| Flecainide Acetate | 20 | $230 | $12 |
| Spironolactone | 27 | $209 | $8 |
| Verapamil | 12 | $186 | $15 |
| Benazepril | 13 | $158 | $12 |
| Hydrochlorothiazide | 15 | $99 | $7 |
| Hydralazine | 11 | $85 | $8 |
| Atenolol | 12 | $72 | $6 |
2014: 21 drugs
| Pradaxa | 19 | $11,709 | $616 |
| Xarelto | 23 | $9,907 | $431 |
| Crestor | 22 | $6,793 | $309 |
| Bystolic | 38 | $5,264 | $139 |
| Clopidogrel | 138 | $3,501 | $25 |
| Diovan | 11 | $2,609 | $237 |
| Isosorbide Mononitrate Er | 102 | $1,925 | $19 |
| Metoprolol | 19 | $1,851 | $97 |
| Carvedilol | 122 | $1,297 | $11 |
| Atorvastatin | 34 | $1,008 | $30 |
| Amlodipine Besylate | 95 | $951 | $10 |
| Losartan | 75 | $865 | $12 |
| Simvastatin | 71 | $770 | $11 |
| Lisinopril | 104 | $728 | $7 |
| Metoprolol | 96 | $720 | $7 |
| Amiodarone | 12 | $686 | $57 |
| Diltiazem 24hr Cd | 12 | $484 | $40 |
| Nitrostat | 15 | $353 | $24 |
| Enalapril Maleate | 13 | $296 | $23 |
| Warfarin | 29 | $284 | $10 |
| Furosemide | 45 | $189 | $4 |
2013: 11 drugs
| Crestor | 22 | $6,307 | $287 |
| Clopidogrel | 53 | $2,495 | $47 |
| Bystolic | 14 | $1,345 | $96 |
| Metoprolol | 12 | $1,180 | $98 |
| Isosorbide Mononitrate Er | 54 | $923 | $17 |
| Carvedilol | 48 | $637 | $13 |
| Lisinopril | 58 | $420 | $7 |
| Losartan | 15 | $398 | $27 |
| Amlodipine Besylate | 34 | $340 | $10 |
| Metoprolol | 34 | $270 | $8 |
| Simvastatin | 19 | $203 | $11 |
Money from drug and device companies
$3,293 in 2025
| 2025 | 11 | 89 | None | $3,293 |
| 2024 | 18 | 155 | $14,464 | $25,189 |
| 2023 | 17 | 151 | None | $7,380 |
| 2022 | 25 | 166 | None | $17,060 |
| 2021 | 17 | 119 | $360 | $5,638 |
| 2020 | 12 | 77 | None | $4,248 |
| 2019 | 16 | 117 | None | $5,586 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Watchman Flx | $899 | 24 payments
|
| Abbott Laboratories | Amplatzer Amulet | $550 | 10 payments
|
| Medtronic | Corevalve Evolut R | $431 | 8 payments
|
| Heartflow | Ffrct | $343 | 2 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $322 | 11 payments
|
| Abiomed | None | $236 | 3 payments
|
See all 89 published payments
| Boston Scientific | Meals · 2025-12-30 | Watchman Flx | $28 |
| Pfizer | Meals · 2025-12-29 | Vyndaqel | $2 |
| Pfizer | Meals · 2025-12-29 | Vyndaqel | $11 |
| Edwards Lifesciences | Meals · 2025-12-23 | Sapien 3 Ultra Resilia | $30 |
| Pfizer | Meals · 2025-12-22 | Vyndaqel | $8 |
| Abiomed | Meals · 2025-12-18 | None | $63 |
| Boston Scientific | Meals · 2025-12-18 | Watchman Flx | $13 |
| Boston Scientific | Meals · 2025-12-18 | Watchman Flx | $56 |
| Boston Scientific | Meals · 2025-12-18 | Watchman Flx | $19 |
| Amgen | Meals · 2025-12-18 | Repatha | $5 |
| Edwards Lifesciences | Meals · 2025-12-16 | Sapien 3 Ultra Resilia | $17 |
| Pfizer | Meals · 2025-12-03 | Vyndaqel | $14 |
| Amgen | Meals · 2025-11-24 | Repatha | $19 |
| Boston Scientific | Meals · 2025-11-13 | Farapulse | $7 |
| Amgen | Meals · 2025-11-10 | Repatha | $7 |
| Abiomed | Meals · 2025-11-07 | None | $37 |
| Boston Scientific | Meals · 2025-11-06 | Farapulse | $7 |
| Baxter Healthcare | Meals · 2025-11-05 | Hillrom - Carnation Ambulatory Monitor | $27 |
| Edwards Lifesciences | Meals · 2025-11-04 | Sapien 3 Ultra Resilia | $25 |
| Pfizer | Meals · 2025-10-31 | Vyndaqel | $8 |
| Abbott Laboratories | Meals · 2025-10-31 | Cardiomems | $19 |
| Boston Scientific | Meals · 2025-10-30 | Farapulse | $8 |
| Amgen | Meals · 2025-10-29 | Repatha | $7 |
| Edwards Lifesciences | Meals · 2025-10-27 | Sapien 3 Ultra Resilia | $135 |
| Abbott Laboratories | Meals · 2025-10-27 | Amplatzer Amulet | $4 |
| Edwards Lifesciences | Meals · 2025-10-21 | Sapien 3 Ultra Resilia | $19 |
| Boston Scientific | Meals · 2025-10-16 | Farapulse | $7 |
| Boston Scientific | Meals · 2025-10-15 | Watchman Flx | $15 |
| Medtronic | Meals · 2025-10-13 | Aurora Ev-Icd Mri Surescan | $24 |
| Amgen | Meals · 2025-10-13 | Repatha | $27 |
| Abiomed | Meals · 2025-10-06 | None | $135 |
| Medtronic | Meals · 2025-10-01 | Micra | $154 |
| Amgen | Meals · 2025-09-29 | Repatha | $8 |
| Baxter Healthcare | Meals · 2025-09-23 | Hillrom - Cardiac Ambulatory Monitor | $23 |
| Edwards Lifesciences | Meals · 2025-09-23 | Sapien 3 Ultra Resilia | $17 |
| Amgen | Meals · 2025-09-22 | Repatha | $11 |
| Novartis Pharmaceuticals | Meals · 2025-09-11 | Leqvio | $24 |
| Edwards Lifesciences | Meals · 2025-09-09 | Sapien 3 Ultra Resilia | $15 |
| Medtronic | Meals · 2025-09-08 | Micra | $8 |
| Amgen | Meals · 2025-09-08 | Repatha | $6 |
| Abbott Laboratories | Meals · 2025-09-05 | Amplatzer Amulet | $95 |
| Medtronic | Meals · 2025-08-22 | Corevalve Evolut R | $74 |
| Abbott Laboratories | Meals · 2025-08-19 | Cardiomems | $125 |
| Amgen | Meals · 2025-07-30 | Repatha | $8 |
| Medtronic | Meals · 2025-07-29 | Corevalve Evolut R | $4 |
| Boston Scientific | Meals · 2025-07-25 | Watchman Flx | $26 |
| Boston Scientific | Meals · 2025-07-24 | Watchman Flx | $74 |
| Edwards Lifesciences | Meals · 2025-07-24 | Sapien 3 Ultra Resilia | $18 |
| Edwards Lifesciences | Meals · 2025-07-24 | Sapien 3 Ultra Resilia | $22 |
| Abbott Laboratories | Meals · 2025-07-23 | Amplatzer Amulet | $29 |
| Abbott Laboratories | Meals · 2025-07-21 | Amplatzer Amulet | $56 |
| Abbott Laboratories | Meals · 2025-07-21 | Amplatzer Amulet | $32 |
| Medtronic | Meals · 2025-07-03 | Corevalve Evolut R | $88 |
| Boston Scientific | Meals · 2025-06-27 | Watchman Flx | $14 |
| Pfizer | Meals · 2025-06-25 | Vyndaqel | $7 |
| Medtronic | Meals · 2025-06-24 | Corevalve Evolut R | $44 |
| Amgen | Meals · 2025-06-23 | Repatha | $8 |
| Edwards Lifesciences | Meals · 2025-06-17 | Sapien 3 Ultra Resilia | $14 |
| Pfizer | Meals · 2025-06-11 | Vyndaqel | $37 |
| Boston Scientific | Meals · 2025-06-02 | Watchman Access System | $121 |
| Baxter Healthcare | Meals · 2025-05-21 | Hillrom - Carnation Ambulatory Monitor | $31 |
| Amgen | Meals · 2025-05-20 | Repatha | $14 |
| Abbott Laboratories | Meals · 2025-05-08 | Mitraclip | $43 |
| Abbott Laboratories | Meals · 2025-05-05 | Amplatzer Amulet | $24 |
| Pfizer | Meals · 2025-04-30 | Eliquis | $28 |
| Amgen | Meals · 2025-04-28 | Repatha | $29 |
| Heartflow | Meals · 2025-04-24 | Ffrct | $126 |
| Heartflow | Meals · 2025-04-14 | Ffrct | $218 |
| Boston Scientific | Meals · 2025-04-08 | Watchman | $9 |
| Pfizer | Meals · 2025-04-07 | Vyndaqel | $28 |
| Pfizer | Meals · 2025-03-26 | Vyndaqel | $5 |
| Edwards Lifesciences | Meals · 2025-03-18 | Sapien 3 Ultra Resilia | $9 |
| Boston Scientific | Meals · 2025-03-11 | Watchman Flx | $11 |
| Novartis Pharmaceuticals | Meals · 2025-03-08 | Leqvio | $30 |
| Boston Scientific | Meals · 2025-03-05 | Watchman Flx | $135 |
| Medtronic | Meals · 2025-03-04 | Corevalve Evolut R | $37 |
| Boston Scientific | Meals · 2025-02-27 | Watchman Flx | $13 |
| Boston Scientific | Meals · 2025-02-27 | Farapulse | $36 |
| Boston Scientific | Meals · 2025-02-22 | General - Therapies | $85 |
| Boston Scientific | Meals · 2025-02-19 | Jetstream Sc | $53 |
| Boston Scientific | Meals · 2025-02-13 | Watchman Access System | $87 |
| Amgen | Meals · 2025-02-12 | Repatha | $9 |
| Boston Scientific | Meals · 2025-02-05 | Watchman Flx | $52 |
| Amgen | Meals · 2025-01-29 | Repatha | $31 |
| Abbott Laboratories | Meals · 2025-01-28 | Amplatzer Amulet | $123 |
| Bard Peripheral Vascular | Meals · 2025-01-27 | True Flow | $14 |
| Novartis Pharmaceuticals | Meals · 2025-01-23 | Leqvio | $23 |
| Boston Scientific | Meals · 2025-01-16 | Avvigo Guidance System | $19 |
| Boston Scientific | Meals · 2025-01-16 | Watchman Flx | $7 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $25,189
| Medtronic | Corevalve Evolut R | $21,441 | 61 payments
|
| Boston Scientific | Watchman Flx | $1,051 | 32 payments
|
| Abbott Laboratories | Mitraclip | $890 | 9 payments
|
| Biotronik | Acticor 7 Vr-T Dx | $460 | 4 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $401 | 12 payments
|
| Amgen | Repatha | $182 | 7 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $180 | 10 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $119 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $100 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $76 | 4 payments
|
| Philips North America | (5044) Mcot | $56 | 2 payments
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $56 | 2 payments
|
| Inari Medical | Flowtriever Catheter, S | $51 | 1 payment
|
| Abiomed | Impella | $28 | 1 payment
|
| W. L. Gore & Associates | Gore Cardioform Septal Occluder | $27 | 1 payment
|
| Pfizer | Vyndaqel | $25 | 1 payment
|
| Lexicon Pharmaceuticals | None | $23 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $23 | 1 payment
|
2023: $7,380
| Medtronic | Corevalve Evolut R | $1,968 | 35 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $1,878 | 30 payments
|
| Boston Scientific | Watchman Access System | $1,492 | 39 payments
|
| Abbott Laboratories | Cardiomems | $885 | 14 payments
|
| Impulse Dynamics (USA) | Optimizer | $203 | 3 payments
|
| Inari Medical | Flowtriever Catheter, S | $185 | 1 payment
|
| Amgen | Repatha | $183 | 7 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $147 | 7 payments
|
| Biotronik | Biomonitor | $119 | 2 payments
|
| Abiomed | Impella | $63 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $51 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $51 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $41 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $41 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $37 | 2 payments
|
| iRhythm Technologies | Zio Xt Patch | $19 | 1 payment
|
| Lexicon Pharmaceuticals | Inpefa | $17 | 1 payment
|
2022: $17,060
| Medtronic | Corevalve Evolut R | $9,741 | 31 payments
|
| Boston Scientific | Watchman Access System | $2,332 | 43 payments
|
| Abbott Laboratories | Cardiomems | $2,159 | 26 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $478 | 6 payments
|
| Biotronik | Orsiro Mission | $404 | 5 payments
|
| W. L. Gore & Associates | Gore Cardioform Septal Occluder | $342 | 3 payments
|
| Impulse Dynamics (USA) | Optimizer | $293 | 6 payments
|
| Abiomed | Impella | $220 | 1 payment
|
| AtriCure | Synergy Ablation System | $217 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $129 | 10 payments
|
| Merck Sharp & Dohme | Verquvo | $128 | 6 payments
|
| Novartis Pharmaceuticals | Leqvio | $127 | 6 payments
|
| Cardiovascular Systems | Diamondback Coronary | $101 | 1 payment
|
| Amgen | Repatha | $93 | 5 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $87 | 4 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $37 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $25 | 1 payment
|
| iRhythm Technologies | Zio Xt Patch | $24 | 1 payment
|
| Terumo Medical | Angio-Seal | $22 | 1 payment
|
| Cordis US | Radial 360 | $21 | 1 payment
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $20 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $16 | 1 payment
|
| Pfizer | Vyndaqel | $15 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $15 | 1 payment
|
| Philips Electronics North America | (9266) Elca | $14 | 1 payment
|
2021: $5,638
| Abbott Laboratories | Cardiomems Hf System | $2,204 | 26 payments
|
| Medtronic | Corevalve Evolut | $883 | 27 payments
|
| Cardiovascular Systems | Diamondback Coronary | $631 | 5 payments
|
| Boston Scientific | Watchman | $505 | 24 payments
|
| Biotronik | Rivacor | $397 | 5 payments
|
| W. L. Gore & Associates | Gore Cardioform Septal Occluder | $299 | 5 payments
|
| Novartis Pharmaceuticals | Entresto | $154 | 9 payments
|
| Abiomed | Impella | $144 | 2 payments
|
| CardioFocus | Heartlight System | $126 | 1 payment
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $114 | 5 payments
|
| Amgen | Repatha | $53 | 3 payments
|
| Merck Sharp & Dohme | Verquvo | $36 | 2 payments
|
| Amarin Pharma | Vascepa | $24 | 1 payment
|
| iRhythm Technologies | Zio Patch | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $19 | 1 payment
|
| Pfizer | Eliquis | $15 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $12 | 1 payment
|
2020: $4,248
| Abbott Laboratories | Cardiomems Hf System | $1,544 | 19 payments
|
| Cardiovascular Systems | Coronary Orbital Atherectomy System | $696 | 8 payments
|
| CathWorks | Ffrangio System | $653 | 10 payments
|
| Boston Scientific | General - Structural Heart | $611 | 15 payments
|
| Medtronic Vascular | 3f | $372 | 8 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $118 | 7 payments
|
| Novartis Pharmaceuticals | Entresto | $100 | 5 payments
|
| Biotronik | None | $79 | 1 payment
|
| Amgen | Repatha | $24 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $21 | 1 payment
|
| Chiesi USA | Kengreal 50mg/10ml L | $19 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $12 | 1 payment
|
2019: $5,586
| Abbott Laboratories | Cardiomems Hf System | $1,601 | 27 payments
|
| Boston Scientific | Synergy | $1,213 | 25 payments
|
| Medtronic Vascular | 3f | $868 | 22 payments
|
| CathWorks | Ffrangio System | $600 | 10 payments
|
| Biotronik | None | $412 | 8 payments
|
| Novartis Pharmaceuticals | Entresto | $175 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $163 | 7 payments
|
| Ge Healthcare | None | $134 | 2 payments
|
| Cardiovascular Systems | Coronary Orbital Atherectomy System | $130 | 2 payments
|
| Amgen | Repatha | $122 | 2 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $43 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $42 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $22 | 1 payment
|
| Braemar Manufacturing | Cardiac Monitoring Suite | $22 | 1 payment
|
| Pfizer | Eliquis | $20 | 1 payment
|
| iRhythm Technologies | Zio Patch | $19 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 97.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1205883972
- Licence
- CA A87860California A87860: Current · expires 2027-12-31
- Trained
- University of California, San Francisco School of Medicine, 2003
- Group
- St. Helena Hospital · Adventist Health Physicians Network · Ukiah Adventist Hospital
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 999 Adams St Ste 106, Saint Helena, CA, 94574
- NPI first listed
- 2006-05-28
- NPI last updated
- 2018-02-20
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305